- Home
- ANTX vs PRT Comparison
ANTX vs PRT Comparison
Compare ANTX & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- PRT
- Stock Information
- Founded
- ANTX 2017
- PRT 2017
- Country
- ANTX United States
- PRT United States
- Employees
- ANTX 36
- PRT N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- PRT Oil & Gas Production
- Sector
- ANTX Health Care
- PRT Energy
- Exchange
- ANTX Nasdaq
- PRT Nasdaq
- Market Cap
- ANTX 40.0M
- PRT 45.9M
- IPO Year
- ANTX 2022
- PRT N/A
- Fundamental
- Price
- ANTX $1.34
- PRT $4.03
- Analyst Decision
- ANTX Hold
- PRT
- Analyst Count
- ANTX 5
- PRT 0
- Target Price
- ANTX $3.50
- PRT N/A
- AVG Volume (30 Days)
- ANTX 1.0M
- PRT 53.8K
- Earning Date
- ANTX 11-13-2024
- PRT 11-13-2024
- Dividend Yield
- ANTX N/A
- PRT 8.96%
- EPS Growth
- ANTX N/A
- PRT N/A
- EPS
- ANTX N/A
- PRT 0.42
- Revenue
- ANTX N/A
- PRT $6,059,380.00
- Revenue This Year
- ANTX N/A
- PRT N/A
- Revenue Next Year
- ANTX N/A
- PRT N/A
- P/E Ratio
- ANTX N/A
- PRT $9.46
- Revenue Growth
- ANTX N/A
- PRT N/A
- 52 Week Low
- ANTX $0.87
- PRT $3.58
- 52 Week High
- ANTX $22.22
- PRT $5.13
- Technical
- Relative Strength Index (RSI)
- ANTX 72.02
- PRT 56.65
- Support Level
- ANTX $0.98
- PRT $3.87
- Resistance Level
- ANTX $1.46
- PRT $4.05
- Average True Range (ATR)
- ANTX 0.08
- PRT 0.12
- MACD
- ANTX 0.03
- PRT 0.02
- Stochastic Oscillator
- ANTX 75.26
- PRT 93.42
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive 80% of the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.